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Abstract
 
Background
 
Central pontine myelinolysis (CPM) usually presents in chronic alcoholics and in patients in whom
hyponatraemia has been corrected rapidly. However, CPM may occur in other clinical circumstances, including patients
with severe hypoglycaemia. We describe the occurrence of CPM and quadriplegia in a patient who experienced fluoro-
quinolone-associated severe hypoglycaemia.
 
Case report
 
A 63-year-old man with Type 2 diabetes mellitus was admitted to hospital for resection of a large liposarcoma.
Renal-dose levofloxacin was utilized as part of an antimicrobial regimen to treat post-operative peritonitis. On days 6–8
of levofloxacin therapy, the patient experienced recurrent hypoglycaemia despite total parenteral nutrition, 10% dextrose
containing fluids and cessation of insulin therapy 3 days prior to the first hypoglycaemic episode. Hypoglycaemia
resolved within 24 h of stopping levofloxacin. After a final and severe hypoglycaemic event, the patient developed quadriplegia
and tonic left deviation of gaze. Magnetic resonance imaging revealed a high-intensity lesion in the central pons consistent
with CPM.
 
Conclusions
 
Fluoroquinolones should be considered as a potential cause of hypoglycaemia. Severe hypoglycaemia has
the potential to cause white matter lesions in the pons. Putative mechanisms include failure of membrane ion channels,
oligodendrocyte apoptosis and oxidative stress of glucose reperfusion. Fluoroquinolone-associated hypoglycaemia and
hypoglycaemia-induced quadriplegia are both rare and we believe this is the first case report linking the two events.
Diabet. Med. 25, 856–859 (2008)
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Introduction
 
Central pontine myelinolysis (CPM) is a serious neurological
disorder of brain white matter initially described in alcoholics
and malnourished patients [1]. It may also occur if hyponat-
raemia is corrected too rapidly [2]. Liver transplantation and
haemodialysis patients have accounted for an increasing
proportion of cases in recent years [3]. Although rare,
hypoglycaemia has been reported to cause CPM [4–6]. The
exact pathogenesis of the disorder remains unclear.
Fluoroquinolones are a class of antibiotics that inhibit
bacterial DNA synthesis and are used to treat a wide variety of
infections. Disorders of glucose homeostasis have been reported
in association with fluoroquinolone therapy, in particular
gatifloxacin and levofloxacin. A report of two population-
based, nested case–control studies of elderly adults treated
in hospital for hypoglycaemia or hyperglycaemia after
ambulatory treatment with a fluoroquinolone, cephalosporin,
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or macrolide found significantly increased risks of both
hypoglycaemia and hyperglycaemia for gatifloxacin-treated
patients and an increased risk of hypoglycaemia for patients
treated with levofloxacin [7]. Gatifloxacin was withdrawn
from the US and Canadian markets in June 2006 because of
treatment-related glucose disturbances.
We present the case of a patient who experienced recurrent
hypoglycaemia while receiving levofloxacin. After a severe
hypoglycaemic event, the patient developed quadriplegia as a
result of CPM.
 
Case report
 
A 63-year-old man presented to hospital with increasing
abdominal distension. He had Type 2 diabetes mellitus,
managed with glibenclamide. A large, low-grade liposarcoma
was removed along with the involved left kidney. Tumour
resection was complicated by bowel perforation and three
additional surgical procedures were performed for partial bowel
resection and peritoneal debridement. Fluconazole, metronidazole
and renal-dosed levofloxacin were administered for treatment
of peritonitis. Adrenal insufficiency was diagnosed and
managed with stress-dose parenteral hydrocortisone (50 mg
every 8 h). Renal function worsened after left nephrectomy
(peak creatinine 361 
 
µ
 
mol/l), but electrolytes remained
unremarkable and no signs of uraemia or fluid overload were
observed. During a prolonged stay in the Intensive Care Unit
(ICU), total parenteral nutrition (TPN, 0.83  mol/l glucose,
104 ml/h) was started and an ICU insulin infusion protocol
was utilized to manage hyperglycaemia. The patient gradually
recovered, permitting transfer to an Intermediate Care Unit
(IMCU) on hospital day 22. TPN was continued, but the
insulin infusion was stopped after transfer to the IMCU, with
the patient receiving only insulin aspart (Novolog) according
to a supplemental subcutaneous insulin protocol.
On the 27th day of hospital stay, TPN was stopped because
of a malfunctioning venous catheter. Two hours later the
patient experienced neuroglycopenic symptoms and capillary
blood glucose was 2.8 mmol/l. Symptoms abated after intra-
venous administration of 25 ml 50% dextrose. Low capillary
FIGURE 1 Time course of hypoglycaemia 
during levofloxacin therapy (a) and MRI 
imaging of the brain (b). (a) Recurrent episodes 
of hypoglycaemia occurred during days 6–8 of 
levofloxacin despite delivery of glucose in TPN 
or fluids. The last episode induced a brief 
cardiopulmonary arrest. (b) T2 weighted MRI 
image of the brain 2 days after the onset of 
quadriplegia. The lesion in the central pons 
(arrow) is consistent with central pontine 
myelinolysis. Note the deviation of the patient’s 
eyes suggesting bulbar involvement. D10, 10% 
dextrose; IVF, intravenous fluids; MRI, 
magnetic resonance image; TPN, total 
parenteral nutrition.
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blood glucose values were corroborated by a laboratory plasma
glucose measurement. There was no insulin in the patient’s
TPN and the last dose of insulin aspart (4 units) had been
administered subcutaneously 5 days before hypoglycaemia
occurred. Ten per cent dextrose (D10) infusion at 104 ml/h
was started after the initial episode of hypoglycaemia. Despite
administration of D10 fluids, the patient required four additional
doses of 50% dextrose to treat recurrent hypoglycaemia on
hospital days 27 and 28 (days 6 and 7 of levofloxacin, see Fig. 1).
TPN was restarted during the evening of hospital day 28
and D10 fluids were stopped. On hospital day 29 (levofloxacin
day 8), the patient suddenly developed cardiac asystole and
required rapid intubation and cardiopulmonary resuscitation.
Capillary blood glucose was 1.1 mmol/l at the time of cardiac
arrest and multiple doses of 50% dextrose were administered
to achieve euglycaemia. Sinus rhythm, normal blood pressure
and spontaneous respiration were restored within 5 min of the
event. However, 24 h later, the patient developed quadriplegia
and tonic ocular deviation to the left. Magnetic resonance
imaging (MRI) revealed a focal high intensity lesion on T-2
weighted images of the central pons (Fig. 1). The lesion also
exhibited prominent intensity on diffusion-weighted images
and reduced intensity on apparent diffusion coefficient (ADC)
mapping. No cortical lesions were observed.
Because of concern about drug-induced hypoglycaemia,
levofloxacin was discontinued. The patient required insulin
therapy for hyperglycaemia within 24 h of stopping levofloxacin.
No other aetiology of hypoglycaemia was identified. The
patient’s last dose of sulphonylurea was prior to admission,
27 days before the onset of hypoglycaemia in hospital and no
insulin was administered in the 5 days before hypoglycaemia.
The patient gradually recovered partial motor function by
the time of hospital discharge with the help of physiotherapy.
Tracheotomy and gastrostomy were performed before transfer
to a nursing home. Unfortunately, the patient returned to the
hospital 1 month later in respiratory failure as a result of
aspiration pneumonia and subsequently died.
 
Discussion
 
To our knowledge, this is the first case of fluoroquinolone-
associated hypoglycaemia complicated by pontine demyelination
and quadriplegia. No alternative explanations are apparent
and hypoglycaemia remitted quickly after levofloxacin was
discontinued. In particular, the patient was not receiving
exogenous insulin when hypoglycaemia occurred, dextrose
was provided in either TPN or intravenous fluids during the
episodes and hydrocortisone at stress doses was prescribed for
adrenal insufficiency. Although high doses of fluconazole can
increase circulating sulphonylurea levels and precipitate
hypoglycaemia [19], our patient had not received any oral
glucose-lowering medication for nearly 1 month before
hypoglycaemia occurred. We are unaware of any reports
documenting metronidazole-induced hypoglycaemia. The
persistent and severe hypoglycaemia and lack of response to a
D10 infusion point to a mechanism other than the discontinuation
of TPN. There were no significant shifts in sodium or potassium
to provide an alternative explanation for CPM. Hypoglycaemia
is a potential cause of cardiac asystole and asystole resolved
after euglycaemia was restored.
Patients most at risk of fluoroquinolone-induced hypogly-
caemia are those with Type 2 diabetes mellitus treated with
sulphonylureas [8,9]. Hypoglycaemia typically occurs 4–6 days
after initiation of a fluoroquinolone antibiotic. Quinolones
have been shown to directly stimulate insulin secretion from
pancreatic B-cells, with at least part of this action occurring by
direct action at pore forming KIR 6.2 subunits of K ATP
channels [10]. In our patient’s case, hypoglycaemia occurred
on day 7 of levofloxacin therapy and resolved promptly after
levofloxacin was stopped.
Severe hypoglycaemia may cause neurological disturbances
ranging from focal deficits to coma and death. However,
reports of hypoglycaemia-induced quadriplegia are rare in the
English language literature [11–13]; one case of quadriplegia
occurred as part of the ‘locked-in’ syndrome [11] and neuro-
logical symptoms in the other two cases resolved quickly after
hypoglycaemia was treated [12,13]. None of these previous
reports has documented pontine lesions on central nervous
system (CNS) imaging.
Shirayama 
 
et al
 
. have reported a case of intentional insulin-
induced hypoglycaemia complicated by left hemiplegia and a
pontine lesion with increased signal intensity on diffusion-
weighted MRI [14]. Hypoglycaemia-induced CPM has also
been reported in patients presenting in coma [4,5] and with
ataxia [6]. Our patient’s only acute lesion on CNS imaging was
an area of high signal intensity in the pons characteristic of
CPM. The patient’s neurological findings can be explained by
disruptions of the corticospinal tract, corticobulbar tract and
paramedian pontine reticular formation.
There are three putative mechanisms by which severe hypo-
glycaemia could cause pontine myelinolysis. Deprivation of
glucose, the major source of fuel for the brain, may lead to
cytotoxic oedema secondary to failure of ion pumps in the cell
membrane [15]. In animal models [15] and at least one patient
[16], enhancement on diffusion-weighted MRI and decreased
signal on ADC mapping as observed for our patient identified
significant changes in brain water diffusion. Glucose resuscitation
resulting in hyperglycaemia activates the NADPH pathway in
neurons, causing cytotoxic oxidative stress [17]. The same
phenomenon could also adversely affect oligodendrocytes.
Finally, hypoglycaemia induces apoptosis pathways in
oligodendrocytes and prevents the maturation of oligodendro-
cyte precursor cells [18].
We believe our case represents hypoglycaemia associated
with fluoroquinolone therapy in a critically ill patient with
renal failure. This case also illustrates two rare complications
of hypoglycaemia, namely CPM and quadriplegia. CPM
appears to be the aetiology of the patient’s quadriplegia. More
studies are required to elucidate the pathogenesis of white
matter brain injury in hypoglycaemia.
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